NCT06992154View on ClinicalTrials.gov

Role of Akkermansia Muciniphila in Acne Vulgaris

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Acne
Interventions
DIETARY_SUPPLEMENT

Akkermansia Muciniphila, Clostridium Beijerinckii, Anaerobutyricum Hallii, Clostridium Butyricum, Bifidobacterium Infantis Probiotic Capsule

Probiotic capsule will contain Akkermansia Muciniphila, Clostridium Beijerinckii, Anaerobutyricum Hallii, Clostridium Butyricum, and Bifidobacterium Infantis

Sponsors

Collaborators (1)

Pendulum Therapeutics
All Listed Sponsors
collaborator

Pendulum Therapeutics

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT06992154 - Role of Akkermansia Muciniphila in Acne Vulgaris | Biotech Hunter | Biotech Hunter